Free Trial

Charles River Laboratories International (CRL) Competitors

Charles River Laboratories International logo
$106.41 +6.66 (+6.68%)
As of 03:58 PM Eastern

CRL vs. MTD, WAT, ILMN, TECH, BIO, BRKR, PACB, HBIO, TMO, and A

Should you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry.

Charles River Laboratories International vs.

Charles River Laboratories International (NYSE:CRL) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, community ranking, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

In the previous week, Charles River Laboratories International had 14 more articles in the media than Mettler-Toledo International. MarketBeat recorded 37 mentions for Charles River Laboratories International and 23 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.28 beat Charles River Laboratories International's score of 0.80 indicating that Mettler-Toledo International is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Charles River Laboratories International
18 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Positive
Mettler-Toledo International
17 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

98.9% of Charles River Laboratories International shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 1.3% of Charles River Laboratories International shares are owned by insiders. Comparatively, 1.9% of Mettler-Toledo International shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Mettler-Toledo International has a net margin of 22.29% compared to Charles River Laboratories International's net margin of 0.52%. Charles River Laboratories International's return on equity of 14.69% beat Mettler-Toledo International's return on equity.

Company Net Margins Return on Equity Return on Assets
Charles River Laboratories International0.52% 14.69% 6.79%
Mettler-Toledo International 22.29%-591.54%26.78%

Charles River Laboratories International has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.28, meaning that its share price is 28% more volatile than the S&P 500.

Charles River Laboratories International currently has a consensus target price of $182.00, suggesting a potential upside of 72.28%. Mettler-Toledo International has a consensus target price of $1,380.50, suggesting a potential upside of 28.19%. Given Charles River Laboratories International's higher probable upside, research analysts clearly believe Charles River Laboratories International is more favorable than Mettler-Toledo International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Charles River Laboratories International
1 Sell rating(s)
15 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.94
Mettler-Toledo International
1 Sell rating(s)
5 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.22

Charles River Laboratories International received 121 more outperform votes than Mettler-Toledo International when rated by MarketBeat users. Likewise, 59.47% of users gave Charles River Laboratories International an outperform vote while only 56.62% of users gave Mettler-Toledo International an outperform vote.

CompanyUnderperformOutperform
Charles River Laboratories InternationalOutperform Votes
493
59.47%
Underperform Votes
336
40.53%
Mettler-Toledo InternationalOutperform Votes
372
56.62%
Underperform Votes
285
43.38%

Mettler-Toledo International has lower revenue, but higher earnings than Charles River Laboratories International. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Charles River Laboratories International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charles River Laboratories International$4.05B1.28$474.62M$0.15704.27
Mettler-Toledo International$3.87B5.80$863.14M$40.5326.57

Summary

Charles River Laboratories International and Mettler-Toledo International tied by winning 9 of the 18 factors compared between the two stocks.

Remove Ads
Get Charles River Laboratories International News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRL vs. The Competition

MetricCharles River Laboratories InternationalCommercial physical research IndustryMedical SectorNYSE Exchange
Market Cap$5.19B$3.10B$5.32B$18.47B
Dividend YieldN/A2.61%5.11%4.25%
P/E Ratio704.2782.4421.6330.90
Price / Sales1.28118.63372.9226.25
Price / Cash7.4834.5738.1517.54
Price / Book1.562.306.374.27
Net Income$474.62M$118.81M$3.20B$1.02B
7 Day Performance-21.14%-1.41%5.06%3.62%
1 Month Performance-38.32%-19.53%-7.61%-7.31%
1 Year Performance-56.23%-16.12%7.03%-0.58%

Charles River Laboratories International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRL
Charles River Laboratories International
4.7701 of 5 stars
$106.41
+6.7%
$182.00
+71.0%
-58.7%$5.23B$4.05B709.4021,800Short Interest ↓
Analyst Revision
News Coverage
Gap Up
High Trading Volume
MTD
Mettler-Toledo International
4.1281 of 5 stars
$1,033.42
+1.1%
$1,380.50
+33.6%
-17.4%$21.54B$3.87B25.5018,000News Coverage
Positive News
Gap Up
High Trading Volume
WAT
Waters
4.1177 of 5 stars
$325.12
+0.1%
$401.31
+23.4%
+0.9%$19.32B$2.96B30.368,200Gap Up
High Trading Volume
ILMN
Illumina
4.5357 of 5 stars
$73.45
-1.0%
$140.65
+91.5%
-41.2%$11.63B$4.37B-9.569,030High Trading Volume
TECH
Bio-Techne
4.9002 of 5 stars
$52.31
+1.1%
$81.25
+55.3%
-24.0%$8.27B$1.20B52.843,100Analyst Revision
Positive News
Gap Down
High Trading Volume
BIO
Bio-Rad Laboratories
4.6566 of 5 stars
$229.42
+1.7%
$395.20
+72.3%
-18.3%$6.43B$2.57B-3.538,200Short Interest ↓
Positive News
Gap Up
BRKR
Bruker
4.6111 of 5 stars
$38.70
+6.1%
$68.00
+75.7%
-55.7%$5.87B$3.37B50.928,520Gap Up
High Trading Volume
PACB
Pacific Biosciences of California
2.5713 of 5 stars
$1.32
+7.3%
$2.46
+86.2%
-57.1%$393.17M$154.01M-0.80730Positive News
Gap Down
HBIO
Harvard Bioscience
3.6293 of 5 stars
$0.38
-4.9%
$4.50
+1,082.7%
-90.6%$16.77M$94.14M-1.15490Analyst Forecast
Gap Up
TMO
Thermo Fisher Scientific
4.9347 of 5 stars
$437.80
0.0%
$653.23
+49.2%
-22.5%$165.16B$42.88B26.49130,000Positive News
Gap Up
High Trading Volume
A
Agilent Technologies
4.6612 of 5 stars
$103.48
+0.5%
$150.83
+45.8%
-27.1%$29.50B$6.51B23.7917,900Positive News
Gap Up
Remove Ads

Related Companies and Tools


This page (NYSE:CRL) was last updated on 4/14/2025 by MarketBeat.com Staff
From Our Partners